CR-CP Life Science Fund

CR-CP Life Science Fund operates as a venture capital entity, strategically deploying capital into early to growth-stage enterprises within the life science sector. The fund's investment thesis spans a broad spectrum of medical innovation, targeting companies developing drugs, advanced cell therapies, sophisticated medical devices, and smart healthcare technologies, alongside interests in biotechnology, artificial intelligence, and machine learning applications in health. This specialized focus enables the fund to support the evolution of critical healthcare solutions.

The fund was established through a collaborative effort, managed jointly by Charoen Pokphand Group and China Resources Capital Management. This partnership was forged on the insight of leveraging the substantial pharmaceutical and medical infrastructure and expertise of its parent organizations. The foundational premise is to identify and nurture groundbreaking life science advancements, particularly those with potential for global impact and strategic introduction into the Chinese market.

CR-CP Life Science Fund primarily serves innovative life science companies seeking capital and strategic partnership for development and commercialization. The fund aims to accelerate the availability of advanced medical solutions by backing promising ventures across pharmaceuticals, medical technology, and digital health. Its long-term vision is to be a catalyst for healthcare progress, facilitating the global diffusion of pioneering scientific and technological breakthroughs to improve patient outcomes worldwide.